Prof. Shi Junyi – Chief Physician of Thyroid & Breast Surgery at Changhai Hospital, Naval Medical University Shanghai

Prof. Shi Junyi  – Chief Physician of Thyroid & Breast Surgery at Changhai Hospital, Naval Medical University Shanghai

About Prof. Shi Junyi

Prof. Shi Junyi   is a Chief Physician (主任医师), Professor, and Clinical Medical Doctor in the Department of Thyroid and Breast Surgery at Changhai Hospital (First Affiliated Hospital of Naval Medical University) in Shanghai. With over 20 years of dedicated clinical practice in general surgery with a focus on breast cancer comprehensive treatment and thyroid disease management, Prof. Shi is a senior specialist within one of Shanghai's established thyroid and breast surgery programs.

Prof. Shi has been recognized as a Shanghai Young Science and Technology Rising Star (上海市青年科技启明星) — a competitive honor awarded by the Shanghai Municipal Science and Technology Commission to outstanding young researchers — reflecting the quality and impact of his early-career scientific contributions. He serves as Deputy Group Leader of the Thyroid and Breast Section of the General Surgery Committee of the People's Liberation Army, a national military medical leadership role, and sits on the editorial board of the journal Breast Disease (乳腺疾病).

Prof. Shi has published over 100 papers and authored 2 medical monographs totaling more than 500,000 characters — a substantial academic output that reflects sustained research productivity across his career. His research includes deep investigation into the surgical treatment of Hashimoto's thyroiditis, a condition at the intersection of autoimmune thyroid disease and thyroid surgery that requires nuanced clinical judgment.

Clinical Expertise

  • Breast cancer comprehensive treatment — breast-conserving surgery, mastectomy, sentinel lymph node biopsy, and axillary dissection; coordination of surgery with chemotherapy, radiation, targeted therapy, and endocrine therapy for complete breast cancer management
  • Thyroid disease diagnosis and treatment — surgical and non-surgical management of thyroid cancer, thyroid nodules, goiter, and thyroid inflammatory conditions
  • Hashimoto's thyroiditis surgical treatment — specialized research and clinical experience in the surgical management of Hashimoto's thyroiditis (chronic lymphocytic thyroiditis), including cases with compressive symptoms, coexisting thyroid cancer, or diagnostic uncertainty
  • Thyroid cancer surgery — total thyroidectomy, hemithyroidectomy, and neck dissection for papillary, follicular, and medullary thyroid carcinoma
  • General surgery — broad clinical foundation in general surgical conditions developed over 20+ years of practice

Why Prof. Shi Junyi?

Prof. Shi's Shanghai Rising Star recognition and his PLA General Surgery Committee leadership role signal a physician who has distinguished himself both scientifically and institutionally — qualities that translate into a clinical practice informed by rigorous evidence and broad peer recognition.

His specialized research in Hashimoto's thyroiditis surgical treatment addresses a clinical area that is frequently mismanaged. Hashimoto's thyroiditis is the most common cause of hypothyroidism globally, and while most cases are managed medically, a subset of patients develop compressive goiter, coexisting thyroid cancer, or diagnostic uncertainty that requires surgical evaluation. The decision of when and how to operate on a Hashimoto's patient — balancing the risks of surgery against the benefits of symptom relief or cancer exclusion — requires the kind of subspecialty experience that Prof. Shi has developed through dedicated research in this area.

His publication of 100+ papers and 2 monographs also reflects a commitment to knowledge dissemination that benefits the broader medical community — and signals a physician who approaches clinical problems with intellectual rigor.

Hospital: Changhai Hospital, Naval Medical University

Changhai Hospital is one of Shanghai's major academic medical centers, with particular strengths in gastroenterology, oncology, and surgery. As a military-affiliated academic hospital, it combines rigorous clinical standards with strong research infrastructure. The Department of Thyroid and Breast Surgery provides comprehensive surgical and medical management of thyroid and breast conditions, with close collaboration between surgery, endocrinology, oncology, and nuclear medicine.

About Hashimoto's Thyroiditis & Surgical Considerations

Hashimoto's thyroiditis (chronic lymphocytic thyroiditis) is the most common autoimmune thyroid disease and the leading cause of hypothyroidism in iodine-sufficient regions. Key facts for international patients:

  • Prevalence: affects approximately 5% of the general population; significantly more common in women (female:male ratio ~7:1)
  • Diagnosis: elevated anti-TPO and anti-thyroglobulin antibodies; ultrasound shows heterogeneous, hypoechoic thyroid parenchyma with reduced vascularity
  • Medical management: levothyroxine replacement for hypothyroidism; most patients do not require surgery
  • Surgical indications: compressive goiter causing dysphagia, dyspnea, or hoarseness; coexisting thyroid nodule with suspicious features requiring biopsy or resection; diagnostic uncertainty between Hashimoto's and thyroid lymphoma; patient preference for definitive treatment
  • Coexisting thyroid cancer: papillary thyroid cancer occurs in approximately 10–15% of Hashimoto's patients undergoing surgery; the inflammatory background can make ultrasound interpretation more challenging, requiring experienced evaluation
  • Surgical considerations: Hashimoto's thyroid tissue is often firmer and more adherent than normal thyroid, requiring experienced surgical technique to minimize complications

What to Prepare Before Your Consultation

For thyroid concerns:

  • Neck ultrasound report with measurements and characteristics of thyroid parenchyma and any nodules
  • Thyroid function tests: TSH, free T4, free T3
  • Thyroid antibodies: anti-TPO, anti-thyroglobulin
  • FNA cytology report if biopsy has been performed
  • CT scan of the neck if compressive symptoms are present

For breast concerns:

  • Mammogram and breast ultrasound reports with BI-RADS scoring
  • Core biopsy pathology report with hormone receptor status (ER, PR, HER2, Ki-67) if breast cancer is confirmed
  • Prior treatment records if previously operated or treated

How CMCS Can Help

China Medical Concierge Shanghai (CMCS) coordinates access to Prof. Shi Junyi and the Changhai Hospital Thyroid and Breast Surgery team for international patients. Our services include remote case review, priority appointment scheduling, full document translation, in-hospital accompaniment, and post-discharge follow-up.

Contact us to begin your case review:

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com

0 commenti

Lascia un commento